A detailed history of Ensign Peak Advisors, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 1,824,228 shares of JNJ stock, worth $266 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
1,824,228
Previous 1,854,068 1.61%
Holding current value
$266 Million
Previous $271 Million 9.09%
% of portfolio
0.53%
Previous 0.5%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $4.34 Million - $4.99 Million
-29,840 Reduced 1.61%
1,824,228 $296 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $17.1 Million - $18.7 Million
-118,455 Reduced 6.01%
1,854,068 $271 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $52 Million - $54.6 Million
-335,258 Reduced 14.53%
1,972,523 $312 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $114 Million - $124 Million
-782,901 Reduced 25.33%
2,307,781 $362 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $139 Million - $156 Million
-892,062 Reduced 22.4%
3,090,682 $481 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $65 Million - $69.9 Million
-421,030 Reduced 9.56%
3,982,744 $659 Million
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $19.8 Million - $23.6 Million
-130,903 Reduced 2.89%
4,403,774 $683 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $33.1 Million - $37.2 Million
-206,882 Reduced 4.36%
4,534,677 $801 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $3.24 Million - $3.61 Million
-20,095 Reduced 0.42%
4,741,559 $775 Million
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $79.5 Million - $87.9 Million
472,425 Added 11.01%
4,761,654 $845 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $173 Million - $197 Million
1,095,909 Added 34.32%
4,289,229 $760 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $76.5 Million - $84.9 Million
490,872 Added 18.16%
3,193,320 $546 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $53.5 Million - $59.5 Million
-331,270 Reduced 10.92%
2,702,448 $436 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $24.9 Million - $26.7 Million
-156,113 Reduced 4.89%
3,033,718 $500 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $27.9 Million - $31.1 Million
-182,290 Reduced 5.41%
3,189,831 $524 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $33.3 Million - $38.2 Million
242,743 Added 7.76%
3,372,121 $531 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $60.9 Million - $66.7 Million
-433,648 Reduced 12.17%
3,129,378 $466 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $103 Million - $124 Million
-800,193 Reduced 18.34%
3,563,026 $501 Million
Q1 2020

May 11, 2020

SELL
$111.14 - $153.99 $7.21 Million - $9.99 Million
-64,870 Reduced 1.46%
4,363,219 $572 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $565 Million - $648 Million
4,428,089 New
4,428,089 $646 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.